ACTBL2 and ovarian cancer: Intending to define the exact cellular composition of ACTBL2-expressing leukocytes in ovarian cancer, various common markers for the most frequent immune cell subtypes have been investigated—CD4 (T-helper cells), FOXP3 (regulatory T-cells) and CD56 for natural killer cells.